1800-272-662
Shopping Cart 0
countryflagAU
Login

Inspire Medical Systems Inc

Healthcare US INSP

59.44USD
-2.45(3.96%)

Last update at 2026-03-10T20:11:00Z

Day Range

58.8662.27
LowHigh

52 Week Range

123.00225.00
LowHigh

Fundamentals

  • Previous Close 61.89
  • Market Cap4502.83M
  • Volume890136
  • P/E Ratio70.03
  • Dividend Yield-%
  • EBITDA58.57M
  • Revenue TTM840.11M
  • Revenue Per Share TTM28.21
  • Gross Profit TTM 711.17M
  • Diluted EPS TTM2.18

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -44.26800M -41.97000M -57.08800M -33.20300M -21.82800M
Minority interest - - - - -
Net income -44.88100M -42.04200M -57.20300M -33.24300M -21.82800M
Selling general administrative 320.69M 202.62M 127.87M 90.47M 53.53M
Selling and marketing expenses - - - - -
Gross profit 341.74M 200.12M 97.76M 68.41M 40.54M
Reconciled depreciation 1.86M 1.22M 0.84M 0.49M 0.39M
Ebit -47.59200M -39.85000M -56.20800M -34.89700M -18.91700M
Ebitda -42.59100M -39.84200M -54.97100M -31.08400M -18.52400M
Depreciation and amortization 5.00M 0.00800M 1.24M 3.81M 0.39M
Non operating income net other 4.88M -0.07600M 1.16M 3.81M 1.85M
Operating income -47.59200M -39.85000M -56.20800M -34.89700M -20.37800M
Other operating expenses 455.45M 273.24M 171.59M 116.95M 70.97M
Interest expense 1.68M 2.13M 2.12M 2.12M 3.30M
Tax provision 0.61M 0.07M 0.12M 0.04M 0.00000M
Interest income 5.05M 0.12M 1.09M 3.80M 1.87M
Net interest income 3.37M -2.00300M -1.02500M 1.68M -1.43400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.61M 0.07M 0.12M 0.04M 1.85M
Total revenue 407.86M 233.39M 115.38M 82.05M 50.59M
Total operating expenses 389.33M 239.97M 153.97M 103.30M 60.91M
Cost of revenue 66.11M 33.28M 17.62M 13.64M 10.06M
Total other income expense net 3.32M -2.12000M -0.88000M 1.69M -0.01600M
Discontinued operations - - - - -
Net income from continuing ops -44.88100M -42.04200M -57.20300M -33.24300M -21.82800M
Net income applicable to common shares -44.88100M -42.04200M -57.20300M -33.24300M -21.82800M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 808.38M 676.81M 564.88M 295.08M 281.19M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 12.07M 9.60M 5.50M 2.66M 1.97M
Total liab 118.69M 104.30M 68.87M 66.04M 51.44M
Total stockholder equity 689.70M 572.51M 496.01M 229.05M 229.75M
Deferred long term liab - - - - -
Other current liab 48.20M 39.27M 33.00M 20.45M 13.52M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings -291.91400M -345.42300M -324.27000M -279.38900M -237.34700M
Other liab - - 0.15M 0.13M 0.09M
Good will - - - - -
Other assets - - 0.21M 0.20M 6.01M
Cash 150.15M 185.54M 441.59M 214.47M 190.52M
Cash and equivalents - - - - -
Total current liabilities 88.50M 78.11M 61.19M 41.31M 20.73M
Current deferred revenue - - - - -
Net debt -118.35700M -160.69100M -432.72000M -180.68400M -159.88600M
Short term debt - - 1.34M 9.19M 3.31M
Short long term debt - - - 9.19M -
Short long term debt total 31.79M 24.85M 8.87M 33.78M 30.63M
Other stockholder equity 981.04M 917.11M 820.34M 508.46M 467.04M
Property plant equipment - - 17.25M 16.41M 5.31M
Total current assets 630.81M 593.74M 530.03M 268.54M 269.87M
Long term investments 71.00M 9.14M 0.00000M 9.94M 0.00000M
Net tangible assets - - 496.01M 229.05M 229.75M
Short term investments 295.40M 274.84M 9.82M 0.00000M 43.84M
Net receivables 93.07M 89.88M 61.23M 34.18M 25.06M
Long term debt - - - 15.80M 24.75M
Inventory 80.12M 33.88M 11.89M 17.23M 8.48M
Accounts payable 38.69M 38.84M 26.85M 11.66M 7.21M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.54M 0.80M -0.08600M -0.05500M 0.03M
Additional paid in capital - - - - -
Common stock total equity - - 0.03M 0.03M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - - -324.27000M -279.38900M -237.34700M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 11.34M 11.28M 10.71M 0.20M 0.20M
Deferred long term asset charges - - - - -
Non current assets total 177.58M 83.07M 34.84M 26.55M 11.32M
Capital lease obligations 31.79M 24.85M 7.54M 8.80M 5.89M
Long term debt total - - - 15.80M 24.75M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -10.50000M 33.81M 89.08M -40.82000M -83.13900M
Change to liabilities 26.30M 11.84M 3.19M 3.98M 4.02M
Total cashflows from investing activities -19.59600M 29.14M 86.63M -43.55900M -83.38900M
Net borrowings -24.50000M -24.50000M -24.50000M -0.53100M 8.00M
Total cash from financing activities 235.08M 14.95M 134.06M 1.96M 190.38M
Change to operating activities 9.13M 6.36M 1.56M 2.04M 2.25M
Net income -44.88100M -42.04200M -57.20300M -33.24300M -21.82800M
Change in cash 227.12M 23.95M 167.66M -74.42800M 88.33M
Begin period cash flow 214.47M 190.52M 22.86M 97.29M 8.96M
End period cash flow 441.59M 214.47M 190.52M 22.86M 97.29M
Total cash from operating activities 11.57M -20.11900M -53.04500M -32.84600M -18.69400M
Issuance of capital stock 243.80M 0.00000M 124.65M 0.00000M 181.82M
Depreciation 1.86M 1.22M 0.84M 0.49M 0.39M
Other cashflows from investing activities - - - -40.82000M -83.13900M
Dividends paid - - - - -
Change to inventory 5.34M -8.75200M -2.64500M -3.16700M 1.00M
Change to account receivables -27.01700M -9.24400M -11.84200M -6.48000M -2.83600M
Sale purchase of stock 3.74M 3.47M 2.36M 1.35M 182.38M
Other cashflows from financing activities 12.04M 11.48M 7.05M 0.61M 8.56M
Change to netincome 51.42M 26.23M 12.73M 6.05M 1.76M
Capital expenditures 9.10M 4.67M 2.46M 2.74M 0.25M
Change receivables -27.01700M -9.24400M -11.84200M -6.48000M -2.83600M
Cash flows other operating -1.45000M 0.38M 1.68M 0.23M -1.23100M
Exchange rate changes - -0.01900M 0.01M 0.01M 0.03M
Cash and cash equivalents changes 227.05M 23.95M 167.66M -74.42800M 88.33M
Change in working capital 1.81M -6.85500M -10.87800M -6.57400M 0.86M
Stock based compensation 51.97M 26.18M 12.82M 6.20M 1.22M
Other non cash items 0.81M 1.37M 1.40M 1.26M 0.71M
Free cash flow 2.47M -24.78700M -55.50000M -35.58500M -18.94400M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
INSP
Inspire Medical Systems Inc		 -2.45 3.96% 59.44 70.03 67.11 5.36 7.08 4.96 51.47
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems Inc

5500 Wayzata Blvd., Golden Valley, MN, United States, 55416

Key Executives

Name Title Year Born
Mr. Timothy P. Herbert CEO, Pres & Director 1963
Mr. Richard J. Buchholz Chief Financial Officer 1968
Mr. Philip J. Ebeling Chief Operating Officer 1971
Mr. Bryan K. Phillips Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. 1971
Mr. Randall A. Ban Chief Commercial Officer 1965
Mr. John C. Rondoni Chief Technology Officer NA
Mr. Martin A. Abrams VP of Marketing & Customer Experience NA
Mr. Steven L. Jandrich VP of HR 1967
Mr. Ivan Lubogo Sr. VP of U.S. Sales NA
Mr. Andreas Henke Sr. VP & MD of Europe NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.